Capmatinib在 MET 14外显子突变或 MET扩增非小细胞肺癌中的疗效及安全性
评价者：崔久嵬1, 文献合成者：高玉儿2

Efficacy and Safety of Capmatinib in METExon 14 Mutated or METAmplified Non-Small-Cell Lung Cancer
Reviewer：CUI Jiu-wei1, Literature Co-worker：GAO Yu-er2